133 Houndsditch | Liverpool St | London
4-5 February, 2020
Showcase opportunities exist in the 2020 congress for companies looking to raise finance (Inv€$table) and / or attract interest in a licensing deal (Lic€n$able)
These showcases are for all stages of private and public companies to present news and deal flow or pitch an audience of active investors, pharma, medtech commercial leaders and big tech.
Inv€$table and Lic€n$able showcases are 15-minute showcase slots allowing companies to deliver succinct, hard hitting and insightful presentations to an audience seeking to uncover innovative research and/or technology for capital and strategic transactions, and licensing and R&D collaborations.
Presenting company executives will present to a live audience, plus have their showcases video recorded and turned into a post-event strategic communications piece.
If you need a platform to announce news/deal flow, are actively looking to raise capital or attract licensing partners, then a showcase is your best opportunity to get noticed at the LSX World Congress.
- Biotech showcase opportunities exist for, but not exclusively: Drug Discovery, Pre-Clinical, Clinical and OTM Therapeutics companies.
- Medtech showcase opportunities exist for MedSurg, IV Diagnostics, Devices, Medical Imaging and Orthopaedic companies
- Healthtech showcase opportunities exist for, but not exclusively: Digital Health, AI, Big Data, Blockchain, Predictive Analytics and Machine Learning companies.
PLUS, NEW FOR 2020, Pharma BD&L Executives are able to position their company as a 'Therapeutic Partner of Choice' and headline 1 of 5 therapeutic sector sessions with their licensing, partnering preferences and external innovation strategies. Each presentation will headline a specific therapeutic licensing session followed by 6 targeted showcases.
In total, 90 showcases will be delivered at the congress. To secure one, enquire below.